The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors associated with early cachexia in metastatic NSCLC: A nationwide Veterans Health Administration analysis.
 
Kamya Sankar
Consulting or Advisory Role - AstraZeneca
Research Funding - Amgen (Inst); Black Diamond Therapeutics (Inst); Genentech/Roche (Inst); Harpoon therapeutics (Inst); Lilly (Inst); Merck (Inst); Summit Therapeutics (Inst)
 
Alex Bryant
No Relationships to Disclose
 
Reena Datta
No Relationships to Disclose
 
Karen Reckamp
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Lilly; Genentech; GlaxoSmithKline; ImmunityBio; Johnson & Johnson/Janssen; Merus; Novartis; Novocare; Nuvation Bio; Pfizer
Research Funding - BioNTech SE (Inst); Blueprint Medicines; Daiichi Sankyo/Astra Zeneca (Inst); Elevation Oncology (Inst); Genentech/Roche (Inst); Johnson & Johnson/Janssen (Inst)
 
Puneeth Iyengar
Employment - Memorial Sloan-Kettering Cancer Center
Consulting or Advisory Role - AstraZeneca; Johnson and Johnson; NGM Biopharmaceuticals
Research Funding - Incyte (Inst)
 
Jane Figueiredo
No Relationships to Disclose
 
Nithya Ramnath
No Relationships to Disclose
 
Neil Bhowmick
Leadership - Enviro Therapeutics Inc.; Kairos Pharma
Stock and Other Ownership Interests - Fibrobiologics; Kairos Pharma
Consulting or Advisory Role - Fibrobiologics; Kairos Pharma
Patents, Royalties, Other Intellectual Property - Patents on Carotuximab